Fresh with a rebrand, Cyllene will advance gene therapies built on a platform that uses a modified form of the herpes virus ...

Vertex makes its largest-ever deal, skyrocketing health insurance costs, and more biotech news from The Readout ...

Vertex claimed the two drugs in the deal could eventually bring in more than $5 billion annually. Still, the high price it ...

Vertex Pharmaceuticals is buying an endocrine treatment specialist for $10 billion.

Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders ...

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

Founded by MIT-Trained Scientists, Biotech Startup Advances Predictive AI to Improve Human Safety Assessment, Reduce Costly Drug Attrition and Accelerate Drug Development BOSTON, MA / ACCESS Newswire ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging ...

Obesity-focused clinical-stage biotechnology company Kalohexis on Tuesday confidentially filed to go public in the ​U.S., adding to an activity rebound ‌in the initial public offering market.

Following an independent salary analysis, this landmark certification sets a benchmark for data-driven pay equity and ...

Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...

Island Pharmaceutical’s experimental drug will be used to treat patients in Uganda, as the African nation grapples with the ...